Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product
Status PubMed-not-MEDLINE Jazyk angličtina Země Francie Médium print
Typ dokumentu tisková chyba
PubMed
33180232
PubMed Central
PMC7701060
DOI
10.1007/s11523-020-00772-4
PII: 10.1007/s11523-020-00772-4
Knihovny.cz E-zdroje
- Publikační typ
- tisková chyba MeSH
Page 608, 4 Discussion, right column, second paragraph.
Amgen Inc Thousand Oaks CA USA
Division of Hematology and Oncology University of Leipzig Liebigstr 19 04106 Leipzig Germany
Gosford Hospital Gosford NSW Australia
Hematology Department ASST Spedali Civili Brescia Brescia Italy
Lithuanian University of Health Sciences Kaunas Lithuania
Oncology Hematology and Cell Therapy Centre Hospitalier Universitaire de Poitiers Poitiers France
School of Medicine Aichi Medical University Nagakute Aichi Nagoya Japan
Schulich School of Medicine Western University Windsor ON Canada
Citace poskytuje Crossref.org
